TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response December 28, 2012